This video examines the late effects of estrogen deprivation in both younger and older breast cancer patients, including bone thinning, heart disease, and dementia.
Treatment with aromatase inhibitors exposes patients to late effects, including the risk of bone thinning, heart disease, and dementia.
In this video Ann Partridge, MD, MPH, of the Dana-Farber Cancer Institute in Boston, discusses how to monitor for and manage these late effects of estrogen deprivation in both younger and older breast cancer patients.